|
SOCS7 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.54942999999186E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.900400E-02 |
| Normal-vs-Stage2 |
2.498200E-02 |
| Normal-vs-Stage3 |
6.62120003269706E-09 |
| Normal-vs-Stage4 |
1.431250E-04 |
| Stage1-vs-Stage2 |
2.868000E-01 |
| Stage1-vs-Stage3 |
2.30029999999104E-05 |
| Stage1-vs-Stage4 |
8.079800E-03 |
| Stage2-vs-Stage3 |
1.105580E-01 |
| Stage2-vs-Stage4 |
2.169800E-01 |
| Stage3-vs-Stage4 |
9.875000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.39550000002975E-06 |
| Normal-vs-AfricanAmerican |
4.584400E-02 |
| Normal-vs-Asian |
7.605600E-01 |
| Caucasian-vs-AfricanAmerican |
5.946400E-01 |
| Caucasian-vs-Asian |
1.211830E-01 |
| AfricanAmerican-vs-Asian |
2.584800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.82740000032445E-07 |
| Normal-vs-Female |
1.346330E-02 |
| Male-vs-Female |
9.816000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.983000E-03 |
| Normal-vs-Age(41-60Yrs) |
4.803200E-03 |
| Normal-vs-Age(61-80Yrs) |
1.55859999995123E-06 |
| Normal-vs-Age(81-100Yrs) |
2.378100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.918800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.601200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.037400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.317610E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.883800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.018200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.611000E-01 |
| Normal-vs-Grade 2 |
6.879500E-03 |
| Normal-vs-Grade 3 |
1.777880E-04 |
| Normal-vs-Grade 4 |
1.04689590330054E-11 |
| Grade 1-vs-Grade 2 |
1.522590E-01 |
| Grade 1-vs-Grade 3 |
9.566300E-02 |
| Grade 1-vs-Grade 4 |
6.40319999999361E-05 |
| Grade 2-vs-Grade 3 |
1.463370E-01 |
| Grade 2-vs-Grade 4 |
3.33749999970046E-07 |
| Grade 3-vs-Grade 4 |
9.625200E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.396200E-01 |
| Normal-vs-ccB subtype |
8.17140000108907E-08 |
| ccA subtype-vs-ccB subtype |
4.78589999997059E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.93359999997889E-06 |
| Normal-vs-N1 |
1.396990E-04 |
| N0-vs-N1 |
2.610200E-01 |
|
|
